BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Oct 31, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-10-29

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-29	Common Stock	M	4655	$17.54	Acquired	103855	Direct
2014-10-29	Common Stock	M	5770	$17.33	Acquired	109625	Direct
2014-10-29	Common Stock	M	35037	$38.59	Acquired	144662	Direct
2014-10-29	Common Stock	S	45462	$81.0997	Disposed	99200	Direct
2014-10-30	Common Stock	M	27372	$38.59	Acquired	126572	Direct
2014-10-30	Common Stock	M	2591	$38.59	Acquired	129163	Direct
2014-10-30	Common Stock	S	29963	$81.6994	Disposed	99200	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-29	Stock Option (right to buy) Common Stock	$17.54	A	4655	Acquired	2016-11-20	Common Stock (4655)	Direct
2014-10-29	Stock Option (right to buy) Common Stock	$17.33	A	5770	Acquired	2017-06-07	Common Stock (5770)	Direct
2014-10-29	Stock Option (right to buy) Common Stock	$38.59	A	35037	Acquired	2018-05-21	Common Stock (35037)	Direct
2014-10-30	Stock Option (right to buy) Common Stock	$38.59	A	27372	Acquired	2018-05-21	Common Stock (27372)	Direct
2014-10-30	Stock Option (right to buy) Common Stock	$38.59	A	2591	Acquired	2018-05-21	Common Stock (2591)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23889	Indirect

Footnotes

F1: The price in column 4 is a weighted average price. The price actually received ranged from $81.00 to $81.53. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $81.00 to $81.96. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Option grant vests 6/48ths on May 20, 2007 and 1/48th on the 20th day of every month thereafter.

F4: Option grant vests 6/48ths on December 7, 2007 and 1/48th on the 7th day of every month thereafter.

F5: Option grant vests 6/48ths on November 22, 2008 and 1/48th on the 22nd day of every month thereafter.

F6: Option grant vests 6/48ths on November 22, 2008 and 1/48th on the 22nd day of every month thereafter.

F7: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.